Compare Agilent Technologies Inc (A) vs Danaos Corporation (DAC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Danaos Corporation — how do they compare? Agilent Technologies Inc trades at $128.24 (market cap $37.04B), while Danaos Corporation trades at $126.27 (market cap $2.27B). The key difference: Agilent Technologies Inc is far larger — about 16.3× Danaos Corporation's market cap, and Danaos Corporation pays the higher dividend (2.88%). Which is the better fit depends on your goals.
| A | DAC | |
|---|---|---|
Market Cap | $37.04B | $2.27B |
Sector | Health | Technology |
52-Week High | $157.20 | $134.63 |
52-Week Low | $110.24 | $84.05 |
Enterprise Value | $38.59B | $2.28B |
Dividend Yield | 0.78% | 2.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Danaos Corporation (DAC) trades at $125.34, up 2.47% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with a P/E of 4.42 and net income margin near 50%, supported by consistent dividend payments. Recent earnings beat expectations in two of the last three quarters, with Q2 2026 results pending.
Outlook remains positive due to deep value metrics and robust cash flow, but risks include cyclical shipping demand and capital expenditure pressures. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid solid operational performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Danaos Corporation
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →
